N
NuPathe
Developing solutions for diseases of the cns, including neurological and psychiatric disorders
About NuPathe
Nupathe.com operates as a global aggregator for health and medical products, providing consumers with access to the best deals on a wide range of items across the health, medical, and wellness sectors. The platform serves individual consumers, healthcare professionals, and wellness enthusiasts by offering a comprehensive selection of products that cater to various health needs. Nupathe.com operates in the e-commerce market, specifically focusing on the health and wellness niche. The business model is based on aggregating products from various suppliers and earning revenue through affiliate marketing, commissions, and advertising. By partnering with multiple vendors, Nupathe.com ensures that users can find competitive prices and a broad selection of products. The company also provides valuable content on health and wellness topics, enhancing user engagement and driving traffic to the site.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2005
- Headquarters
- Malvern, United States
- Open positions
- None listed
- Dealroom signal
- 24.3/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Oncology, Neurology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Jan 2014 | $144M | $144M | Undisclosed | — |
| GROWTH EQUITY VCOther financing | Oct 2012 | $28M | — | Undisclosed | — |
Growth signals
Latest recorded traffic for NuPathe is 1.2K monthly website visits, up 313.8% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
BioAdvance
Series A6 investors entered at this stage
Birchmere Ventures
Safeguard Scientifics
Quaker Bio Ventures
SR One- BCBay City Capital
Battelle Ventures
Other known investors2 additional known investors
Ben Franklin Technology Partners of Southeastern Pennsylvania
Project Liberty Digital Incubator
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about NuPathe on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See NuPathe’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.